
|Videos|February 9, 2021
Managing secondary glaucoma due to intravitreal steroids
Author(s)OT Staff Reports
L. Jay Katz, MD, of the Wills Eye Hospital, Philadelphia, PA, discusses the highlights of his Glaucoma 360 presentation on secondary glaucoma due to intravitreal steroids, and what ophthalmologists can do to minimize the risk of severe visual impairment in patients.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
2
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
3
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
4
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
5


























